Anebulo Pharmaceuticals ANEB
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q2 | 2.73 | 103.88 | -0.05 | -1,340 | -1 | |
| 2024Q1 | 2.87 | 104.39 | -0.07 | -1,664 | -2 | |
| 2023Q4 | 2.42 | 102.79 | -0.10 | -2,760 | -3 | |
| 2023Q3 | 3.06 | 102.54 | -0.10 | -2,544 | -2 | |
| 2023Q2 | 2.35 | 99.96 | -0.10 | -2,494 | -2 | |
| 2023Q1 | 2.90 | 102.36 | -0.11 | -2,864 | -3 | |
| 2022Q4 | 2.42 | 99.63 | -0.15 | -3,813 | -4 | |
| 2022Q3 | 2.80 | -0.11 | -2,612 | -3 | ||
| 2022Q2 | 5.20 | 100.13 | -0.10 | -2,325 | -2 | |
| 2022Q1 | 7.08 | 100.16 | -0.08 | -1,880 | -2 | |
| 2021Q4 | 6.15 | 99.81 | -0.04 | -1,071 | -1 | |
| 2021Q3 | 6.55 | 100.13 | -0.07 | -1,555 | -2 | |
| 2021Q2 | 6.82 | 8.54 | -2.09 | -2,485 | -29 | |
| 2021Q1 | 101.47 | -0.69 | -552 | -1 | ||
| 2020Q4 | -0.01 | -325 | 0 | |||
| 2020Q3 | -252 | 0 |